Terms & Conditions

Welcome to Pharma Journal. These Terms and Conditions ("Terms") govern your use of the Pharma Journal website located at pharma-journal.com ("Platform"), including all content, services, and functionality offered through the Platform.

By accessing or using our Platform, you agree to be bound by these Terms. If you do not agree to these Terms, you must not use the Platform. These Terms constitute a legally binding agreement between you and Pharma Journal (operated by Teksyte LTD), a company registered in England & Wales. If you are accessing or using the Platform on behalf of a business, partnership, company or other entity, you represent and warrant that you have full authority to bind that entity to these Terms.

• "Platform" refers to the Pharma Journal website and all associated services.
• "User" refers to any individual or entity accessing the Platform.
• "Content" means all articles, news, data, text, images, graphics, and other materials published on the Platform.
• "Listing" refers to a company directory entry published on the Platform.
• "Sponsored Content" means editorial or promotional material published in exchange for payment.
• "We", "Our", "Us", "Company" refers to Pharma Journal (operated by Teksyte LTD), registered in England & Wales.
• "User Content" refers to any Content submitted, uploaded, posted or otherwise made available to the Platform by a User (including listing details, logos, photographs and enquiry messages).
• "AI-Generated Content" refers to Content produced in whole or in part by artificial-intelligence systems operated by or on behalf of the Company.

The Platform is an online business directory and editorial publication for the pharmaceutical and life-sciences industry. It lists third-party companies (manufacturers, CDMOs, CROs, biotechnology firms, clinics, suppliers and service providers) that have registered with us, submitted information to us, or that we have identified through publicly available sources. We are not a broker, agent, intermediary, introducer, guarantor or fiduciary for any listed company, and we do not conduct, endorse, underwrite, insure or supervise any transaction, engagement or interaction between a User and a listed company.

Listings are provided "as is" on a good-faith basis. Company descriptions, contact details, capabilities, certifications, accreditations and service claims are supplied by the listed company or drawn from third-party sources and may change without notice. You acknowledge that you rely on any listing at your own risk and that any contractual or commercial relationship you enter into with a listed company is strictly between you and that company.

Inclusion in the directory does not imply that the Company has verified the regulatory status, licences, GMP/GDP certification, ISO accreditation, insurance, financial standing or business practices of a listed company. Users are encouraged to perform their own due diligence — including verification with the MHRA, EMA, FDA or other competent authority — before entering into any engagement.

All Content on the Platform — including articles on clinical trials, drug development, treatments, regulatory affairs and market analysis — is published for general information and industry-news purposes only. It does not constitute, and must not be relied upon as, medical advice, clinical guidance, diagnosis or treatment recommendations; regulatory or legal advice; or investment, financial or professional advice of any kind.

Nothing on the Platform is intended to promote any medicinal product, nor to be an advertisement for a prescription-only medicine within the meaning of the Human Medicines Regulations 2012 or the ABPI Code of Practice. References to products, molecules, therapies or trial results are editorial in nature.

Always consult a qualified healthcare professional on medical matters, a qualified regulatory professional on compliance matters, and an authorised financial adviser on investment matters. The Company accepts no liability for decisions taken in reliance on Content published on the Platform.

You agree to use the Platform only for lawful purposes and in accordance with these Terms. You must not:

• Use the Platform in any way that violates applicable UK or international law or regulation.
• Transmit any unsolicited advertising, promotional material, or spam.
• Attempt to gain unauthorised access to any part of the Platform, its servers, or connected databases.
• Use automated tools (scrapers, bots, crawlers) to extract content without prior written permission.
• Reproduce, distribute, or republish content from the Platform without authorisation.
• Impersonate any person or entity or misrepresent your affiliation with any person or entity.

Certain features of the Platform may require you to create an account. When you create an account:

• You must provide accurate, current, and complete information.
• You are responsible for maintaining the confidentiality of your login credentials.
• You are responsible for all activity that occurs under your account.
• You must notify us immediately of any unauthorised use of your account.

We reserve the right to suspend or terminate accounts that violate these Terms or that have been inactive for an extended period.

You retain ownership of any intellectual-property rights you already hold in User Content. However, you are solely responsible for User Content you submit and for the consequences of submitting it.

You warrant that User Content you submit (including company descriptions, photographs, logos and any other material):

• is owned by you, or you have obtained all necessary licences, consents and permissions (including photographer and model releases where applicable) to submit it to the Platform and grant the licences in Section 8;
• does not infringe any copyright, trade mark, design right, database right, confidential-information right, privacy right or other intellectual-property or proprietary right of any third party;
• does not contain defamatory, threatening, obscene, harassing, unlawful or otherwise objectionable material;
• complies with all applicable laws and regulations (including, without limitation, the Business Protection from Misleading Marketing Regulations 2008, the Human Medicines Regulations 2012 in respect of any product claims, and the UK GDPR in respect of any personal data contained in it);
• does not contain malware, viruses, cryptominers, tracking pixels or any other harmful code.

You agree to indemnify, defend and hold harmless the Company, its directors, officers, employees and agents from and against any and all claims, damages, losses, liabilities, costs and expenses (including reasonable legal fees) arising from (i) your User Content, (ii) your breach of these Terms, or (iii) your violation of any third-party right or applicable law.

By submitting User Content to the Platform, you grant the Company a worldwide, non-exclusive, royalty-free, transferable, sub-licensable licence to use, reproduce, adapt, publish, translate, create derivative works from, distribute, perform and display that User Content on the Platform and in any media now known or later developed, for the purposes of operating, promoting and improving the Platform, including marketing, social-media promotion of your Listing, and syndication to partner directories.

This licence survives termination of your account in respect of (a) content already distributed or cached by third parties, and (b) archival and backup copies necessary to operate the Platform. You may request removal of specific User Content by emailing info@pharma-journal.com; we will act on reasonable requests within 30 days.

Images displayed on the Platform fall into three categories, each with distinct rights and disclaimers:

(a) Client-supplied images. Company logos, facility photographs and product imagery on individual Listings are supplied by the listed company when they request a Listing be created or updated. The listed company warrants to us that they own or have properly licensed all rights in those images, including rights from photographers, subjects, brand owners and other rights-holders. The Company is not in a position to independently verify these rights and expressly disclaims responsibility for their accuracy. If you are a rights-holder and believe an image has been published on the Platform without your permission, please follow the takedown procedure in Section 10 below.

(b) Third-party stock or editorial images. Hero images, category tiles and illustrative imagery may be sourced from licensed stock libraries (e.g. Unsplash, Shutterstock) or obtained under editorial fair-dealing exceptions of the Copyright, Designs and Patents Act 1988. Where attribution is required by the applicable licence, credit is provided on the same page or in the image caption.

(c) AI-generated images. Some editorial and illustrative images published on the Platform — particularly alongside articles and category landing pages — are produced in whole or in part by artificial-intelligence image-generation systems. AI-generated images on this Platform:

• are illustrative only and are not photographs of real people, real facilities, real products or specific events unless explicitly stated;
• are generated from prompts we author, using systems whose output licence permits commercial use;
• are not intended to depict any identifiable living person, and any resemblance to a real individual is coincidental;
• must not be relied on to assess the appearance, equipment, certification status or current trading condition of any specific company or facility.

You agree that you will not use any image from the Platform outside the Platform without our express prior written permission.

We respect intellectual-property rights and respond promptly to credible complaints. If you believe Content on the Platform infringes your copyright, trade mark or other right, please email info@pharma-journal.com with the following information:

• a description of the work you claim has been infringed;
• the specific URL(s) on the Platform where the allegedly infringing material appears;
• evidence of your ownership of, or authorisation to act on behalf of the owner of, the right claimed;
• your full name, business address, email and a phone number;
• a statement that you have a good-faith belief that the use complained of is not authorised.

We will acknowledge credible takedown requests within 5 business days and will act on them, where appropriate, within a reasonable period. Knowingly submitting a false takedown request may expose the sender to liability for damages, including costs and legal fees.

All content on the Platform, including but not limited to articles, reports, analyses, graphics, logos, and design elements, is the intellectual property of Pharma Journal or its content licensors and is protected by UK and international copyright laws.

You may view and print pages from the Platform for your own personal, non-commercial use, subject to the restrictions set out in these Terms. You must not reproduce, distribute, modify, create derivative works from, or publicly display any content without our prior written consent.

Submission

Companies may submit listings to our pharmaceutical directory. By submitting a listing, you represent and warrant that all information provided is accurate, complete, and not misleading. We reserve the right to review, edit, or reject any listing at our sole discretion.

Accuracy

Listed companies are solely responsible for ensuring the accuracy and currency of their listing information. Pharma Journal does not verify or endorse any claims made in directory listings and accepts no liability for inaccurate or outdated information.

Removal

We reserve the right to remove any listing that violates these Terms, contains inaccurate information, or is deemed inappropriate for our platform. Listing holders may request removal of their listing by contacting us in writing.

Pharma Journal publishes sponsored content and advertisements from pharmaceutical companies and related organisations. All sponsored content is clearly labelled and distinguished from independent editorial content.

Advertisers are responsible for ensuring that their content complies with all applicable laws and regulations, including the Medicines and Healthcare products Regulatory Agency (MHRA) advertising guidelines and the ABPI Code of Practice.

Pharma Journal reserves the right to refuse, modify, or remove any advertising or sponsored content at its discretion. Publication of advertising does not constitute endorsement by Pharma Journal.

The content on this Platform is provided for general informational purposes only and does not constitute medical, pharmaceutical, legal, or professional advice. While we endeavour to keep information accurate and up-to-date, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability of the content.

To the fullest extent permitted by law, Pharma Journal shall not be liable for any indirect, incidental, special, consequential, or punitive damages, or any loss of profits, revenue, data, or business opportunities arising from your use of or inability to use the Platform.

You agree to indemnify, defend, and hold harmless Pharma Journal, its officers, directors, employees, and agents from and against any and all claims, liabilities, damages, losses, and expenses (including reasonable legal fees) arising from or related to your use of the Platform, your violation of these Terms, or your violation of any rights of a third party.

These Terms shall be governed by and construed in accordance with the laws of England and Wales. Any disputes arising under or in connection with these Terms shall be subject to the exclusive jurisdiction of the courts of England and Wales. Nothing in these Terms shall affect your statutory rights as a consumer under applicable UK law.

In the event of a dispute arising from or relating to these Terms, both parties agree to first attempt to resolve the matter through good-faith negotiation. If the dispute cannot be resolved informally within 30 days, either party may commence formal proceedings.

For EU-based users, you may also use the European Commission's Online Dispute Resolution platform. Nothing in this clause limits your right to bring proceedings in the courts of your country of residence if required by applicable consumer protection law.

If any provision of these Terms is held to be invalid, illegal or unenforceable by a court of competent jurisdiction, that provision shall be modified to the minimum extent necessary to make it enforceable, and the remaining provisions shall continue in full force and effect.

No failure or delay by the Company in exercising any right under these Terms shall operate as a waiver of that right, nor shall any single or partial exercise preclude any further exercise of that or any other right.

These Terms, together with our Privacy Policy and Cookie Policy, constitute the entire agreement between you and the Company regarding the Platform and supersede all prior agreements and understandings, whether written or oral.

We reserve the right to modify these Terms at any time. Changes will be effective immediately upon posting to the Platform. We will indicate the date of the last revision at the bottom of this page. Your continued use of the Platform after any changes constitutes acceptance of the modified Terms. We encourage you to review these Terms periodically.

If you have any questions or concerns about these Terms and Conditions, please contact us:

• Email: info@pharma-journal.com
• Website: pharma-journal.com/contact